Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion type Assertion NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_head.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_provenance.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion evidence source_evidence_literature NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_provenance.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion SIO_000772 17259654 NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_provenance.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion wasDerivedFrom befree-20150227 NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_provenance.
- NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_assertion wasGeneratedBy ECO_0000203 NP217337.RAi5Nf7VfvBUKlki-rs0A0roSmY-PaeZ8bqTOVVvfXaRc130_provenance.